CDR-Life Inc’s $76 Million Series A Financing Round

Homburger advised CDR-Life in the transaction.

CDR-Life Inc, a Swiss biotechnology company pioneering a new and differentiated class of highly tumor-specific immune-oncology therapeutics, announced the closing of its USD 76 m Series A financing led by Jeito Capital and RA Capital Management, with participation from Omega Funds.

The Homburger team was led by partner Daniel Häusermann (Picture) and included lead associate Marc Schamaun as well as associates Anna Peter, Daniel Kuhn (all Corporate / M&A), associate Philippe Weber (Tax) and junior associate Lars Schöni. 

Involved fees earner: Daniel Häusermann – Homburger; Daniel Kuhn – Homburger; Anna Peter – Homburger; Marc Schamaun – Homburger; Lars Schöni – Homburger; Philippe Weber – Homburger;

Law Firms: Homburger;

Clients: CDR-Life;

Federica Tiefenthaler

Author: Federica Tiefenthaler